DANHSON is a pharmaceutically-oriented holding company, established in Bulgaria in 2015, by professionals with long experience in the field. The core business is development, production and marketing of pharmaceutical products (RX and OTC), food supplements and cosmetics.


дансон лого


This company is specialised in manufacturing small volume sterile liquids (ampoule formulation), non-sterile liquids for internal application (syrups, oral suspensions), semisolid pharmaceutical forms (gels and ointments) and biologically active pharmaceuticals, liquids for external application (shampoos) and medical devices, solid forms – tablets and capsule.

more information >>
дансон лого


We offer distribution and trade of food supplements of controlled and guaranteed quality. The food supplements include supplements for drinking in ampoule formulation, non-sterile liquids for internal application (syrups) and finished solid dosage forms (tablets).

more information >>
дансон лого


Our mission is to keep introducing on the Bulgarian market innovative solutions and develop the portfolio so as to keep meeting the high requirements of customers maintaining at the same time the traditional product quality. The product range of cosmetics includes liquids for external applications (shampoos), semisolid products (creams and ointments).

more information >>
Дансон CPhI

Exhibition CPHI Worldwide 2019

From November 5th up to 7th 2019, at Messe Frankfurt it will take place the Exhibition CPHI Worldwide 2019 dedicated to chemical and pharmaceutical branch operators.
Vetprom Vipharma, will exhibit at Hall 8 stand 80F102
For more information, visit the website https://www.cphi.com/europe/


PHONE  +35924519300

ADDRESS  Radomir, 2400,St. „Otets Paisiy“ 26

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.